Nine Monthly Results Results Snapshot
Figures in Cr
Consolidate Nine Monthly Results
Dec'25
Dec'24
Dec'23
Net Sales
84.51
19.71
20.20
Other Operating Income
0.00
0.00
0.00
Total Operating income
84.51
19.71
20.20
Raw Material Cost
2.72
0.49
0.00
Purchase of Finished goods
84.85
19.24
15.71
(Increase) / Decrease In Stocks
-9.13
-3.46
0.34
Employee Cost
2.80
0.68
0.60
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.01
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
4.04
1.71
3.56
Total Expenditure (Excl Depreciation)
85.27
18.67
20.21
Operating Profit (PBDIT) excl Other Income
-0.76
1.04
-0.01
Other Income
2.14
2.12
0.40
Operating Profit (PBDIT)
1.38
3.16
0.39
Interest
0.76
0.33
0.13
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
0.62
2.83
0.26
Depreciation
1.50
0.56
0.13
Profit Before Tax
-0.88
2.28
0.14
Tax
-0.09
0.49
0.05
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
-0.79
1.79
0.09
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
-0.79
1.79
0.09
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-0.79
1.79
0.09
Equity Capital
55.37
55.37
27.69
Face Value
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
Diluted Earnings per share
-0.02
0.01
0.0
Operating Profit Margin (Excl OI)
-0.9%
5.28%
-0.05%
Gross Profit Margin
0.73%
14.36%
1.29%
PAT Margin
-0.93%
9.08%
0.45%
Public Share Holdings (%)
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
Net Sales
YoY Growth in nine months ended Dec 2025 is 328.77% vs -2.43% in Dec 2024
Consolidate Net Profit
YoY Growth in nine months ended Dec 2025 is -144.13% vs 1,888.89% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in nine months ended Dec 2025 is -173.08% vs 10,500.00% in Dec 2024
Interest
YoY Growth in nine months ended Dec 2025 is 130.30% vs 153.85% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024
Compare Nine Monthly Results Of Genpharmasec With
Figures in Cr
Consolidate Nine Monthly Results
Change(INR)
Change(%)
Net Sales
84.51
0
84.51
Other Operating Income
0.00
0.00
0.00
Total Operating income
84.51
0
84.51
Raw Material Cost
2.72
0
2.72
Purchase of Finished goods
84.85
0
84.85
(Increase) / Decrease In Stocks
-9.13
0
-9.13
Employee Cost
2.80
0
2.80
Power Cost
0.00
0
0.00
Manufacturing Expenses
-0.01
0
-0.01
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
4.04
0.00
4.04
Total Expenditure (Excl Depreciation)
85.27
0
85.27
Operating Profit (PBDIT) excl Other Income
-0.76
0.00
-0.76
Other Income
2.14
0
2.14
Operating Profit (PBDIT)
1.38
0
1.38
Interest
0.76
0
0.76
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
0.62
0
0.62
Depreciation
1.50
0
1.50
Profit Before Tax
-0.88
0
-0.88
Tax
-0.09
0
-0.09
Provisions and contingencies
0.00
0
0.00
Profit After Tax
-0.79
0
-0.79
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
-0.79
0
-0.79
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-0.79
0
-0.79
Equity Capital
55.37
0
55.37
Face Value
1.00
0
0.00
Reserves
0.00
0
0.00
Gross Profit Margin
0.73%
0%
0.00
0.73%
PAT Margin
-0.93%
0%
0.00
-0.93%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 84.51 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 328.77% vs -2.43% in Dec 2024
Nine Monthly - Consolidate Net Profit
Consolidate Net Profit -0.79 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is -144.13% vs 1,888.89% in Dec 2024
Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) -0.76 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is -173.08% vs 10,500.00% in Dec 2024
Nine Monthly - Interest
Interest 0.76 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 130.30% vs 153.85% in Dec 2024
Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -0.90%
in Dec 2025Figures in %
YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
